Fredric Cohen
Cortendo AB
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fredric Cohen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:45 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03621280 · Open-label Treatment in Cushing's SyndromeCortendo AB · completed · Cushing Syndrome, Cushing Disease · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:45 UTC. The ranking covers the 200 most relevant of 23 PubMed records, and a shared surname and initials can bring in a namesake. All 23 on PubMed
- 2,450 citationsRCR 72.7
- 159 citationsRCR 4.1
- Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.Arterioscler Thromb Vasc Biol · 1999134 citationsRCR 3.9
- Deliver us from evil: the effects of mortality salience and reminders of 9/11 on support for President George W. Bush.Pers Soc Psychol Bull · 2004108 citationsRCR 3.6
- Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients.Cancer Epidemiol Biomarkers Prev · 200187 citationsRCR 1.8
- Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial.Lancet Diabetes Endocrinol · 201984 citationsRCR 5.3
- Differential immune system changes with acute and persistent stress for optimists vs pessimists.Brain Behav Immun · 199978 citationsRCR 2.9
- Cognitive-behavioral intervention effects on adolescents' anxiety and pain following spinal fusion surgery.Nurs Res · 200378 citationsRCR 3.3
- Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women.Menopause · 199942 citationsRCR 1.2
- 42 citationsRCR 4.4